Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Abbot, abstention, Actemra, Additionally, adhere, aid, alienate, ambulatory, amyloid, antagonist, Apotex, ASC, assembled, attached, AV, begun, benchmark, benchmarking, beta, Biovitrum, budget, cardiac, carefully, CD, CDARC, CDER, CDs, charter, children, COBRA, contemplated, conviction, cord, CRDAC, creation, database, DBH, dedicated, delegated, dental, deviate, disregard, dopamine, drafting, dramatically, driven, ECG, embezzlement, encapsulate, entirety, ethical, exceed, exemplary, exploratory, faith, fee, fell, felony, filled, fit, formulaic, fragment, frequency, frozen, gathering, grossly, harassment, HCL, hearing, hemodialytic, hydroxylase, imprecise, inaccurate, inconsistent, incremental, inducing, input, insubordination, intangible, Interestingly, introduce, IRS, ixekizumab, job, Kineret, Liaison, Likewise, Lyn, malignant, managerial, mapping, masitinib, median, Medicaid, Merck, messaging, Meyer, misappropriation, misconduct, misjudge, mono, motivate, negligent, neuroleptic, neutrazumab, NMS, NOL, noncompetition, nonpublic, nonsolicitation, norm, NortheraTM, overturn, owed, paper, pateclizumab, Patheon, payout, PDUFA, Pearl, people, pipeline, plaque, plc, polarization, polyneuropathy, PR, psroriatic, QRS, ramp, realign, receptor, recoupment, referenced, Registry, renal, reputation, responding, return, reward, SA, sacrifice, Sandoz, sarilumab, satisfactorily, secukinumab, shipment, Simponi, situated, solicited, soliciting, spinal, spouse, spring, staggered, Substituted, successor, summer, Swedish, tabalumab, TAGP, talent, talented, telephone, Teva, Therof, tock, tool, Topline, Trademark, transformation, triple, unexercised, unpaid, unrestricted, User, vacation, VAS, VI, violation, visual, whichever, wind, winding, writing
Removed:
absence, Academy, add, adenosine, Albany, Allergy, allocate, Alzheimer, amelioration, analgesic, applied, attributable, augment, authored, Axelrod, Baylor, Beth, Biaggioni, biology, biomedical, Boston, BS, Bulletin, calculation, California, Cambridge, Canadian, category, centre, chaired, Clinic, collateralization, complement, consortia, CORRONA, counterparty, covering, creating, DANA, default, Department, Detroit, devoted, diabetic, diagnostic, Diego, dispose, dozen, Dysautonomia, editor, editorial, Edward, Engalaticheff, Eon, Essential, Experimental, extensively, Federation, fellow, fellowship, FFELP, fixed, foundation, founder, founding, franchise, Freeman, Harrow, Harvard, hedge, Horacio, Houston, illiquid, improve, includingHypertension, Institute, interaction, internship, intolerance, investigating, Italo, Jason, Joel, journal, Kaufmann, Kavanaugh, Keystone, King, Kremer, Lee, LeWitt, Macdonald, Maryland, Mayo, MD, Michigan, Minnesota, Missouri, mitigate, modification, Mount, Muscle, Nashville, neural, neurochemical, neurodegenerative, neurology, Neuromuscular, Neuropharmacology, neurophysiology, Neuroscience, nitric, Offsetting, ophthalmologic, oxide, pathophysiology, perspective, Peter, Phillip, physiology, postural, Professor, Psychiatry, rational, Rebecca, recipient, recognizing, recording, regularity, renewal, renowned, requiring, residency, resigned, resumed, reviewer, Rochester, Roy, Saint, secured, shift, Sinai, Southwestern, specialist, specialty, Stanford, steering, Stein, Strand, symmetry, tachycardia, teaching, Temple, Tennessee, Toronto, trained, Transmission, Tremor, UCSD, unprecedented, unpublished, Vanderbilt, Vibeke, Wayne, Wellesley, yearly
Filing tables
Filing exhibits
- 10-K Annual report
- 10.3 2004 Stock Plan, As Amended
- 10.6 Employment Agreement
- 10.17 Manufacturing Services Agreement
- 23.1 Consent of Independent Registered Public Accounting Firm
- 23.2 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification by the Chief Executive Officer Pursuant to Section 240.13A-14
- 31.2 Certification by the Chief Financial Officer Pursuant to Section 240.13A-14
- 32.1 Certification by the Chief Executive Officer Pursuant to 18 U.s.c. 1350
- 32.2 Certification by the Chief Financial Officer Pursuant to 18 U.s.c. 1350
Related press release
CHTP similar filings
Filing view
External links
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Chelsea Therapeutics International, Ltd. (the “Company”) for the period ended December 31, 2011 as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, J. Nick Riehle, Vice President, Administration and Chief Financial Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Report. |
/s/ J. Nick Riehle |
J. Nick Riehle |
Vice President, Administration and Chief Financial Officer |
March 7, 2012 |